We concluded that most demethylation events are likely due to “passive demethylation” preferentially in late-replicating regions following accelerated cell division during malignant transformation caused by genomic and transcriptome changes, although some loss of methylation including that in the IGF2BP3 promoter could be related to tumor progression. The gene discussed is IGF2BP3; the disease is neoplasm.